Shares of Puma Biotechnology have plummeted this year after being one of the strongest performers a year ago. Here’s why this beaten down biotech belongs in your portfolio.
Shares of Puma Biotechnology have plummeted this year after being one of the strongest performers a year ago. Here’s why this beaten down biotech belongs in your portfolio.